Clinical effect of postconditioning in ST-elevation myocardial infarction patients treated with primary percutaneous coronary intervention: a meta-analysis of randomized controlled trials
后适应在接受直接PCI治疗的急性ST段抬高性心肌梗死患者中的临床疗效:基于随机对照试验的meta分析(英文)
摘要
Objective: To evaluate the clinical effect of postconditioning on patients with ST-elevation myocardial infarction (STEMI) treated with primary percutaneous coronary intervention (PCI). Methods: Randomized controlled trials were identified by searching relevant databases published up to April 2nd, 2014. A meta-analysis of eligible studies was performed by Stata 12.0 and Review Manager 5.2 with a fixed-effect model. Results: Ten studies providing adverse cardiac events in a total of 1346 STEMI patients treated with primary PCI were identified. The occurrence of heart failure was significantly reduced in patients treated with postconditioning compared with usual care (risk ratio (RR) 0.533; 95% confidence intervals (CI) 0.368-0.770), whereas non-fatal reinfarction slightly increased in the postconditioning group (RR 2.746; 95% CI 1.007-7.488). No significant difference in total major adverse cardiac events (MACEs) was observed between the two groups (RR 0.876; 95% CI 0.671-1.144). Conclusions: Postcondi- tioning in STEMI patients undergoing primary PCI significantly reduces the risk of heart failure, but fails to decrease the incidence of total MACEs and the risk of non-fatal reinfarction.
目的:探讨后适应对接受直接经皮冠状动脉介入(PCI)治疗的急性ST段抬高性心肌梗死(STEMI)患者心血管不良事件的影响。创新点:进一步明确后适应处理对STEMI患者临床预后的影响。方法:对符合入选标准的随机对照临床试验进行meta分析。结论:缺血后适应显著降低ST段抬高性心肌梗死患者心衰风险。
基金
supported by the Science and Technology Research Program of Jinhua Municipality(No.2014-3-052),China
参考文献44
-
1Argaud, L., Gateau-Roesch, O., Raisky, O., et al., 2005. Postconditioning inhibits mitochondrial permeability transition. Circulation, 111(2):194-197. [doi:10.1161/01. CIR.0000151290.04952.3B].
-
2Bavry, A.A., Kumbhani, D.J., Bhatt, D.L., 2008. Role of adjunctive thrombectomy and embolic protection devices in acute myocardial infarction: a comprehensive meta- analysis of randomized trials. Eur. HeartJ., 29(24):2989- 3001. [doi: 10.1093/eurheartj/ehn421 ].
-
3Burzotta, F., de Vita, M., Gu, Y.L., et al., 2009. Clinical impact of thrombectomy in acute ST-elevation myocardial infarction: an individual patient-data pooled analysis of II trials. Eur. Heart jr., 30(18):2193-2203. [doi: 10.1093/eurheartj/ehp348].
-
4Cohen, M.V., Yang, X.M., Downey, J.M., 2007. The pH hypothesis of postconditioning: staccato reperfusion reintroduces oxygen and perpetuates myocardial acidosis. Circulation, 115(14):1895-1903. [doi:10.1161/CIRCUL ATIONAHA. 106.675710].
-
5de Luca, G., Dudek, D., Sardella, G., et aL, 2008. Adjunctive manual thrombectomy improves myocardial perfusion and mortality in patients undergoing primary pereutaneous coronary intervention for ST-elevation myocardial infarction: a meta-analysis of randomized trials. Eur. Heart J., 29(24):3002-3010. [doi: 10.1093/eurheartj/ehn 389].
-
6de Silva, K., Webb, I., Sicard, P., et al., 2012. Does left ventricular function continue to influence mortality following contemporary percutaneous coronary intervention? Coron. Artery Dis., 23(3):155-161. [doi:10.1097/MCA.0b013e 328351162d].
-
7di Chiara, A., Dall'armellina, E., Badano, L.P., et aL, 2010. Predictive value of cardiac troponin-I compared to creatine kinase-myocardial band for the assessment of infarct size as measured by cardiac magnetic resonance. J. Cardiovasc. Med., 11(8):587-592. [doi:10.2459/JCM. 0b013e3283383153].
-
8Dong, M., Mu, N., Guo, F., et al., 2014. The beneficial effects of postconditioning on no-reflow phenomenon after percutaneous coronary intervention in patients with ST-elevation acute myocardial infarction. J. Thromb. Thrombolysis, 38(2):208-214. [doi:10.1007/sl1239-013- 1010-0].
-
9Egger, M., Smith, G.D., Schneider, M., et al., 1997. Bias in meta-analysis detected by a simple, graphical test. BMJ, 315(7109):629-634. [doi:10.1136fomj.315.7109.629].
-
10Eitel, I., Wohrle, J., Suenkel, H., et al., 2013. Intracoronary compared with intravenous bolus abciximab application during primary percutaneous coronary intervention in ST-segment elevation myocardial infarction: cardiac magnetic resonance substudy of the AIDA STEMI trial. J. Am. Coll. Cardiol., 61(13):1447-1454. [doi:10.1016/j. jacc.2013.01.048].
-
1张令军,黄鹤,潘平喜,刘小菁,吴文超,付华.激活素A在心肌缺血后适应中的表达变化及意义[J].四川大学学报(医学版),2009,40(1):97-99. 被引量:5
-
2陈晓栋,娄彬,于圣永,龚觉晓,谷明林,张一炎,原红.缺血后适应对急性心肌梗死PCI术中再灌注心律失常的疗效评估[J].现代医学,2010,38(3):253-256. 被引量:9
-
3全南虎,郑杨,于宏颖,赵昕.缺血后适应对大鼠心肌缺血再灌注后血流动力学改善的影响[J].中国老年学杂志,2010,30(8):1099-1101. 被引量:4
-
4周菲,穆瑞斌,黄新苗,曹江,郭品娥,秦永文.后适应联合促红细胞生成素对大鼠心肌缺血再灌注损伤的保护作用[J].中华老年心脑血管病杂志,2008,10(12):931-934.
-
5王印华,王宝华,庞楠,唐明贵,柴海霞,轩兴伟,郭炜妍,浦践一.急性心肌梗死再灌注治疗中后适应在梗死相关动脉不同开通时间对再灌注心肌的保护作用[J].中国煤炭工业医学杂志,2016,18(12):1683-1686. 被引量:6
-
6雒生杰,周玉杰,贾德安,杨士伟.远程缺血后适应减轻非糖尿病患者冠状动脉支架术中心肌损伤的研究[J].中国心血管病研究,2016,14(7):604-607.
-
7张苗苗,于海奕,祖凌云,徐明,王贵松,高炜.miR-214在大鼠心肌缺血再灌注损伤及缺血后适应中的表达及机制探讨[J].中国分子心脏病学杂志,2011,11(2):108-112. 被引量:4
-
8张苗苗,毛雯,仝其广,于海奕,高炜.缺血后适应对在体大鼠心肌缺血再灌注损伤的保护作用及其机制[J].中华心血管病杂志,2016,44(7):616-620. 被引量:20
-
9路航,余欣,赵昕.锌对缺血后适应预防糖尿病大鼠心肌缺血再灌注损伤的影响[J].中国老年学杂志,2015,35(11):2961-2963. 被引量:1
-
10张伟,侯彬,杨大成.远距离缺血后适应对急性心肌梗死溶栓再通患者的保护性研究[J].中国医药导报,2009,6(25):13-15. 被引量:4